![]() |
市場調查報告書
商品編碼
1933101
全球男性活力和睪固酮支持類快速消費品市場預測(至2032年),按產品類型、成分類型、配方、分銷管道、最終用戶和地區分類Men's Vitality & Testosterone Support FMCG Market Forecasts to 2032 - Global Analysis By Product Type, Ingredient Type, Formulation, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球男性活力和睪固酮支持快速消費品市場價值將達到 69.3 億美元,在預測期內以 10.1% 的複合年成長率成長,到 2032 年將達到 136 億美元。
男性活力與睪固酮支持類快速消費品(FMCG)是指旨在提升男性能量、耐力、肌肉健康、性慾、情緒和維持健康睪固酮水平的消費品。此類別包括膳食補充劑、機能性食品和飲料、強化營養產品以及使用維生素、礦物質、植物萃取物、蛋白質和適應原的個人健康產品。這些產品專為日常使用而設計,強調便利性、安全性和循證有效性,通常採用潔淨標示。它們透過便利的零售通路銷售,目標客戶是希望提升運動表現、平衡新陳代謝、延緩老齡化並改善整體健康狀況的成年男性,產品銷往全球線上線下市場。
對性腺功能減退症的認知提高
荷爾蒙檢測和健康篩檢準確性的提高提高了診斷率,並鼓勵男性積極主動地管理自身荷爾蒙健康。媒體通報、數位健康平台和健康領域的意見領袖正在向消費者普及疲勞、性慾低下和肌肉流失等症狀。預防性醫療保健的趨勢促使男性消費者傾向於選擇營養補充劑而非處方箋藥。醫療保健專業人員也擴大推薦以生活方式為基礎的睾酮支持產品作為輔助治療手段。男性健康診所和遠端醫療諮詢的普及也提高了男性獲得荷爾蒙相關指導的途徑。
高昂的製造成本和合規成本
製造商必須遵守多個地區的嚴格食品安全標準、原料可追溯性規範和標籤法規。使用經臨床驗證的成分,例如草藥萃取物、維生素和生物活性化合物,會顯著增加採購和配方成本。符合GMP、ISO和潔淨標示標準等認證要求可進一步增加營運成本。小規模品牌在擴大生產規模的同時,往往難以維持合規性和品質一致性。有關健康聲明的法規頻繁更新,也增加了產品核可和市場准入的複雜性。這些成本壓力會限制創新並降低價格競爭力,尤其是在新興市場。
個人化營養與人工智慧
人工智慧驅動的平台使品牌能夠根據年齡、生活方式、生物標記和荷爾蒙水平提供客製化的營養補充劑建議。數據分析和穿戴式健康設備的進步正在改善對健身、睡眠和代謝指標的即時追蹤。消費者越來越傾向於尋求更個人化的解決方案來滿足其獨特的活力需求,而不是千篇一律的處方。個人化的訂閱營養模式有助於提高客戶參與和長期品牌忠誠度。人工智慧與營養基因組學的融合為精準睪酮支持產品開闢了新的可能性。這種向個人化的轉變預計將重塑整個產業的產品開發和行銷策略。
仿冒品/含有非法添加物的產品
含有未申報藥物成分的未經監管產品會損害消費者信任和品牌信心。線上市場和跨境電商通路的激增增加了仿冒品流入消費者手中的風險。這些低品質的替代品往往模仿知名公司的包裝和品牌,造成市場混亂。監管機構在監控數位銷售平台和非正規分銷網路方面面臨挑戰。反覆出現的安全問題導致監管更加嚴格,甚至對合規的製造商也造成了影響。因此,打擊仿冒品品需要增加對防偽技術和供應鏈透明度的投資。
新冠疫情對男性活力和睪固酮支持類快速消費品市場產生了複雜的影響。疫情初期的封鎖措施擾亂了原料採購、生產營運和全球物流網路。隨著健身房和醫療機構准入限制的逐步解除,男性開始在家中進行健康和營養補充。隨著消費者轉向線上購買健康產品,電子商務通路經歷了顯著成長。各大品牌加速推動數位化行銷和直銷策略,以維持市場佔有率。疫情後,市場正優先考慮增強韌性、實現供應鏈多元化以及採用數位化優先的互動模式。
預計在預測期內,營養補充品細分市場將佔據最大的市場佔有率。
由於膳食補充劑具有方便、價格實惠和產品種類繁多等優點,因此預計在預測期內,膳食補充劑領域將佔據最大的市場佔有率。膠囊、片劑、粉末和軟糖等形式的補充劑可以輕鬆融入日常生活。消費者對天然植物性睪固酮增強劑的日益偏好正在推動其普及。含有鋅、維生素D、鎂和草藥萃取物的臨床驗證配方也增強了產品的可信度。積極的行銷、名人代言以及與運動營養領域的整合也進一步推動了銷售。
在預測期內,老年人群將呈現最高的複合年成長率。
預計在預測期內,老年人群將呈現最高的成長率,這主要得益於老年男性對睪固酮支持和活力增強產品的需求。預期壽命的延長促使男性更專注於保持體力、耐力和性功能。老年消費者更願意投資預防性健康解決方案,以維持生活品質。人們對男性更年期和與老齡化相關的代謝變化的認知不斷提高,推動了相關產品的普及。醫療保健專業人員也擴大建議老齡化男性在改變生活方式的同時,進行營養干預。
預計北美將在預測期內佔據最大的市場佔有率,這主要得益於消費者對荷爾蒙健康和預防保健的高度關注。該地區擁有強大的購買力,且優質保健產品供應充足。完善的膳食補充劑監管法規提升了消費者對產品安全性和有效性的信心。透過數位平台和健身日常消費品進行的廣泛行銷也推動了市場擴張。大型快速消費品和營養保健品公司的入駐正在推動創新和產品多元化。
預計亞太地區在預測期內將實現最高的複合年成長率。快速的都市化和生活方式的改變加劇了男性壓力水平和代謝健康問題。可支配收入的成長推動了男性在健康和營養補充劑產品上的支出。在數位健康宣傳活動的支持下,人們對男性健康議題的認知不斷提高,促進了相關產品的普及。電子商務和直銷通路的擴張提高了全部區域產品的可及性。本地製造商正在推出採用傳統草藥成分、符合當地文化習慣的配方。
According to Stratistics MRC, the Global Men's Vitality & Testosterone Support FMCG Market is accounted for $6.93 billion in 2025 and is expected to reach $13.60 billion by 2032 growing at a CAGR of 10.1% during the forecast period. Men's Vitality & Testosterone Support FMCG refers to fast-moving consumer goods formulated to support male energy, stamina, muscle health, libido, mood, and healthy testosterone levels. The category spans supplements, functional foods and beverages, fortified nutrition, and personal wellness products using vitamins, minerals, botanicals, proteins, and adaptogens. Positioned for everyday use, these products emphasize convenience, safety, and evidence-backed benefits, often featuring clean-label claims. They target adult men seeking performance, metabolic balance, healthy aging, and overall wellbeing through accessible retail channels globally across online and offline markets.
Rising awareness of hypogonadism
Increased diagnosis rates, supported by improved hormonal testing and health screenings, are encouraging men to proactively manage hormonal health. Media coverage, digital health platforms, and wellness influencers are educating consumers about symptoms such as fatigue, reduced libido, and muscle loss. Preventive healthcare trends are shifting male consumers toward nutritional solutions rather than prescription therapies. Healthcare professionals are also increasingly recommending lifestyle-based testosterone support products as complementary interventions. The expansion of men's wellness clinics and telehealth consultations has improved accessibility to hormone-related guidance.
High production & compliance costs
Manufacturers must adhere to stringent food safety standards, ingredient traceability norms, and labeling regulations across multiple geographies. The use of clinically backed ingredients such as herbal extracts, vitamins, and bioactive compounds significantly increases sourcing and formulation expenses. Compliance with certifications such as GMP, ISO, and clean-label standards further raises operational costs. Smaller brands often face challenges in scaling production while maintaining regulatory alignment and quality consistency. Frequent regulatory updates related to health claims add complexity to product approvals and market entry timelines. These cost pressures can limit innovation and reduce price competitiveness, particularly in emerging markets.
Personalized nutrition & AI
AI-driven platforms are enabling brands to offer customized supplement recommendations based on age, lifestyle, biomarkers, and hormonal profiles. Advances in data analytics and wearable health devices are improving real-time tracking of fitness, sleep, and metabolic indicators. Consumers are increasingly seeking tailored solutions rather than generic formulations to address individual vitality needs. Subscription-based personalized nutrition models are enhancing customer engagement and long-term brand loyalty. Integration of AI with nutrigenomics is opening new possibilities for precision testosterone support products. This shift toward personalization is expected to reshape product development and marketing strategies across the sector.
Counterfeit & adulterated products
Unregulated products containing undeclared pharmaceutical substances can undermine consumer trust and brand credibility. Online marketplaces and cross-border e-commerce channels have made it easier for counterfeit products to reach consumers. These low-quality alternatives often mimic packaging and branding of established companies, creating market confusion. Regulatory authorities face challenges in monitoring digital sales platforms and informal distribution networks. Repeated safety concerns can trigger stricter regulations, impacting compliant manufacturers. As a result, combating counterfeiting requires increased investment in authentication technologies and supply chain transparency.
The COVID-19 pandemic had a mixed impact on the men's vitality and testosterone support FMCG market. Initial lockdowns disrupted raw material sourcing, manufacturing operations, and global logistics networks. Reduced access to gyms and clinical consultations encouraged men to adopt at-home wellness and supplementation routines. E-commerce channels witnessed strong growth as consumers shifted toward online purchasing of health products. Brands accelerated digital marketing and direct-to-consumer strategies to maintain market presence. Post-pandemic, the market is emphasizing resilience, supply chain diversification, and digital-first engagement models.
The dietary supplements segment is expected to be the largest during the forecast period
The dietary supplements segment is expected to account for the largest market share during the forecast period, due to its convenience, affordability, and wide product availability. Supplements such as capsules, tablets, powders, and gummies are easily integrated into daily routines. Increasing preference for natural and plant-based testosterone boosters is strengthening consumer adoption. Clinically supported formulations containing zinc, vitamin D, magnesium, and herbal extracts are gaining credibility. Aggressive marketing, celebrity endorsements, and sports nutrition cross-over appeal are further driving sales.
The aging population segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the aging population segment is predicted to witness the highest growth rate, due to demand for testosterone support and vitality-enhancing products among older men. Increased life expectancy is encouraging men to focus on maintaining strength, stamina, and sexual health. Older consumers are more willing to invest in preventive wellness solutions to sustain quality of life. Rising awareness of andropause and age-related metabolic changes is boosting product adoption. Healthcare professionals are increasingly recommending nutritional interventions alongside lifestyle modifications for aging men.
During the forecast period, the North America region is expected to hold the largest market share, due to high consumer awareness regarding hormonal health and preventive wellness. The region benefits from strong purchasing power and widespread availability of premium health products. Well-established dietary supplement regulations enhance consumer confidence in product safety and efficacy. Extensive marketing through digital platforms and fitness communities supports market expansion. Presence of leading FMCG and nutraceutical companies drives innovation and product diversification.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization and lifestyle changes are increasing stress levels and metabolic health concerns among men. Rising disposable incomes are enabling higher spending on wellness and nutritional products. Growing awareness of men's health issues, supported by digital health campaigns, is driving product adoption. Expansion of e-commerce and direct-to-consumer channels is improving product accessibility across the region. Local manufacturers are introducing culturally tailored formulations using traditional herbal ingredients.
Key players in the market
Some of the key players in Men's Vitality & Testosterone Support FMCG Market include GNC Holdings, Inc., GlaxoSmithKline plc (GSK), Herbalife Nutrition Ltd., Vitabiotics Ltd., Amway Corporation, Optimum Nutrition, Inc., Pfizer Inc., Blackmores Limited, Bayer AG, Iovate Health Sciences International Inc., NOW Foods, Swisse Wellness Pty Ltd., Nature's Bounty Co., Sanofi S.A., and Abbott Laboratories.
In January 2026, Abbott announced collaboration with AtaCor Medical to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to deliver defibrillation therapy to people with life-threatening heart rhythms.
In September 2025, Pfizer Inc. announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical Co., Limited, a leading innovation-driven global healthcare company, for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor agonist currently in Phase 1 development for chronic weight management.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.